Long-chain polyunsaturated fatty acids: Food for thought(s)

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Long-chain polyunsaturated fatty, acids (LCPUFA, or LCP) are bioactive compounds that include docosahexaenoic acid (DHA) and arachidonic acid. DHA has received the greatest attention, because it appears to be necessary for normal growth and development of the infant brain and visual system. For preterm infants there is wide agreement over the neural functional benefits of LCP, whereas for term infants the results are more controversial. There is growing interest in the practice of supplementing pregnant and breastfeeding women with DHA. LCP may be used in the presence of functional and/or organic brain impairments as well as some inflammatory states, but caution is warranted to prevent false expectations. Therefore, pediatricians should be aware of the present scientific evidence concerning dietary LCP supplementions.

Original languageEnglish
Pages (from-to)319-322
Number of pages4
JournalItalian Journal of Pediatrics
Volume29
Issue number5
Publication statusPublished - Oct 2003

Fingerprint

Docosahexaenoic Acids
Unsaturated Fatty Acids
Brain
Breast Feeding
Growth and Development
Arachidonic Acid
Premature Infants
Pregnant Women

Keywords

  • Docosahexaenoic acid
  • Long-chain Polyunsaturated fatty acids

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Long-chain polyunsaturated fatty acids : Food for thought(s). / Agostoni, Carlo.

In: Italian Journal of Pediatrics, Vol. 29, No. 5, 10.2003, p. 319-322.

Research output: Contribution to journalArticle

@article{4c81c1857bad46478d28d9082b661b24,
title = "Long-chain polyunsaturated fatty acids: Food for thought(s)",
abstract = "Long-chain polyunsaturated fatty, acids (LCPUFA, or LCP) are bioactive compounds that include docosahexaenoic acid (DHA) and arachidonic acid. DHA has received the greatest attention, because it appears to be necessary for normal growth and development of the infant brain and visual system. For preterm infants there is wide agreement over the neural functional benefits of LCP, whereas for term infants the results are more controversial. There is growing interest in the practice of supplementing pregnant and breastfeeding women with DHA. LCP may be used in the presence of functional and/or organic brain impairments as well as some inflammatory states, but caution is warranted to prevent false expectations. Therefore, pediatricians should be aware of the present scientific evidence concerning dietary LCP supplementions.",
keywords = "Docosahexaenoic acid, Long-chain Polyunsaturated fatty acids",
author = "Carlo Agostoni",
year = "2003",
month = "10",
language = "English",
volume = "29",
pages = "319--322",
journal = "Italian Journal of Pediatrics",
issn = "1720-8424",
publisher = "BioMed Central Ltd.",
number = "5",

}

TY - JOUR

T1 - Long-chain polyunsaturated fatty acids

T2 - Food for thought(s)

AU - Agostoni, Carlo

PY - 2003/10

Y1 - 2003/10

N2 - Long-chain polyunsaturated fatty, acids (LCPUFA, or LCP) are bioactive compounds that include docosahexaenoic acid (DHA) and arachidonic acid. DHA has received the greatest attention, because it appears to be necessary for normal growth and development of the infant brain and visual system. For preterm infants there is wide agreement over the neural functional benefits of LCP, whereas for term infants the results are more controversial. There is growing interest in the practice of supplementing pregnant and breastfeeding women with DHA. LCP may be used in the presence of functional and/or organic brain impairments as well as some inflammatory states, but caution is warranted to prevent false expectations. Therefore, pediatricians should be aware of the present scientific evidence concerning dietary LCP supplementions.

AB - Long-chain polyunsaturated fatty, acids (LCPUFA, or LCP) are bioactive compounds that include docosahexaenoic acid (DHA) and arachidonic acid. DHA has received the greatest attention, because it appears to be necessary for normal growth and development of the infant brain and visual system. For preterm infants there is wide agreement over the neural functional benefits of LCP, whereas for term infants the results are more controversial. There is growing interest in the practice of supplementing pregnant and breastfeeding women with DHA. LCP may be used in the presence of functional and/or organic brain impairments as well as some inflammatory states, but caution is warranted to prevent false expectations. Therefore, pediatricians should be aware of the present scientific evidence concerning dietary LCP supplementions.

KW - Docosahexaenoic acid

KW - Long-chain Polyunsaturated fatty acids

UR - http://www.scopus.com/inward/record.url?scp=0347683450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347683450&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0347683450

VL - 29

SP - 319

EP - 322

JO - Italian Journal of Pediatrics

JF - Italian Journal of Pediatrics

SN - 1720-8424

IS - 5

ER -